Rodolfo Carlos, Eusébio Dalinda, Ventura Cathy, Nunes Renato, Florindo Helena F, Costa Diana, Sousa Ângela
CICS-UBI-Health Science Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.
Pharmaceutics. 2021 Aug 31;13(9):1369. doi: 10.3390/pharmaceutics13091369.
In current times, DNA vaccines are seen as a promising approach to treat and prevent diseases, such as virus infections and cancer. Aiming at the production of a functional and effective plasmid DNA (pDNA) delivery system, four chitosan polymers, differing in the molecular weight, were studied using the design of experiments (DoE) tool. These gene delivery systems were formulated by ionotropic gelation and exploring the chitosan and TPP concentrations as DoE inputs to maximize the nanoparticle positive charge and minimize their size and polydispersity index (PDI) as DoE outputs. The obtained linear and quadratic models were statistically significant (-value < 0.05) and non-significant lack of fit, with suitable coefficient of determination and the respective optimal points successfully validated. Furthermore, morphology, stability and cytotoxicity assays were performed to evaluate the endurance of these systems over time and their further potential for future in vitro studies. The subsequent optimization process was successful achieved for the delivery systems based on the four chitosan polymers, in which the smallest particle size was obtained for the carrier containing the 5 kDa chitosan (82 nm), while the nanosystem prepared with the high molecular weight (HMW) chitosan displayed the highest zeta potential (+26.8 mV). Delivery systems were stable in the formulation buffer after a month and did not exhibit toxicity for the cells. In this sense, DoE revealed to be a powerful tool to explore and tailor the characteristics of chitosan/pDNA nanosystems significantly contributing to unraveling an optimum carrier for advancing the DNA vaccines delivery field.
当前,DNA疫苗被视为治疗和预防疾病(如病毒感染和癌症)的一种有前景的方法。为了生产一种功能性且有效的质粒DNA(pDNA)递送系统,使用实验设计(DoE)工具研究了四种分子量不同的壳聚糖聚合物。这些基因递送系统通过离子凝胶法制备,并将壳聚糖和TPP浓度作为DoE输入进行探索,以最大化纳米颗粒的正电荷,并将其尺寸和多分散指数(PDI)作为DoE输出进行最小化。所获得的线性和二次模型具有统计学意义(p值<0.05)且缺乏拟合不显著,具有合适的决定系数,且各自的最佳点已成功验证。此外,还进行了形态学、稳定性和细胞毒性测定,以评估这些系统随时间的耐久性及其在未来体外研究中的进一步潜力。基于四种壳聚糖聚合物的递送系统成功实现了后续优化过程,其中含有5 kDa壳聚糖的载体获得了最小粒径(约82 nm),而用高分子量(HMW)壳聚糖制备的纳米系统显示出最高的zeta电位(约+26.8 mV)。递送系统在配方缓冲液中一个月后仍保持稳定,且对细胞无毒性。从这个意义上说,DoE被证明是一种强大的工具,可用于探索和定制壳聚糖/pDNA纳米系统的特性,为揭示推进DNA疫苗递送领域的最佳载体做出了重大贡献。